Plus Therapeutics, Inc. ( CNSY) - Key Metrics
CNSY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.06 | -$1.33 | -$1.05 | -$1.13 |
| 2026Q1 | $0.15 | -$1.05 | -$0.94 | -$1.06 |
| 2025Q4 | $0.44 | -$1.84 | -$2.01 | -$2.02 |
| 2025Q3 | $325.11 | -$1,029.32 | -$592.97 | -$599.26 |
| 2025Q2 | $718.35 | $2,662.02 | -$2,996.38 | -$3,000 |
CNSY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.77 |
| 2026Q1 | 0% | -0.96 |
| 2025Q4 | 0% | -0.97 |
| 2025Q3 | 0% | 0.00 |
| 2025Q2 | 0% | 0.00 |
CNSY
Price: $3.07
52 week price:
Exchange: NGM
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Market Capitalization: 24.0 million